Index
-
Market Cap
11.25M
Enterprise Value
473.90M
Income
-32.09M
Sales
469.10M
Book/sh
15.29
Cash/sh
2.72
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
1665
IPO
Oct 13, 2006
P/E
-
Forward P/E
0.33
PEG
-
P/S
0.02
P/B
0.02
P/C
0.13
P/FCF
-
EV/EBITDA
6.85
EV/Sales
1.01
Quick Ratio
8.68
Current Ratio
8.68
Debt/Eq
0.14
LT Debt/Eq
0.14
Option/Short
Yes / Yes
EPS (ttm)
-1.02
EPS next Y
1.06
EPS next Q
2.82
EPS this Y
-36.89%
EPS next Y
-10.20%
EPS next 5Y
-13.72%
EPS past 3/5Y
57.24% -
Sales past 3/5Y
10.98% -1.01%
EPS Y/Y TTM
-899.66%
Sales Y/Y TTM
-13.60%
EPS Q/Q
-7.79%
Sales Q/Q
-60.49%
Insider Own
11.71%
Insider Trans
-2.95%
Inst Own
41.53%
Inst Trans
-5.26%
ROA
2.12%
ROE
2.55%
ROIC
2.21%
Gross Margin
-
Oper. Margin
11.94%
Profit Margin
-6.84%
SMA20
-26.15%
SMA50
-43.88%
SMA200
-73.20%
Trades
Shs Outstand
32.28M
Shs Float
28.57M
52W High
5.35 -93.50%
52W Low
0.32 8.62%
Volatility
14.51% 13.29%
ATR (14)
0.06
RSI (14)
29.89
Beta
1.68
Rel Volume
1.19
Avg Volume
432.06K
Volume
515,726
Perf Week
-15.97%
Perf Month
-36.75%
Perf Quarter
-71.73%
Perf Half Y
-77.99%
Perf YTD
-92.44%
Perf Year
-89.51%
Perf 3Y
-95.73%
Perf 5Y
-98.57%
Perf 10Y
-96.47%
Prev Close
0.34
Price
0.35
Change %
0.93%
Analysts 11 incl. previous ratings
Rating Distribution 0 Buy · 11 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Feb 26, 2026 Downgrade C Craig Hallum
Buy → Hold $2 +475.2% Dec 04, 2024 Initiated U UBS
Neutral $5.50 +1,481.8% Jan 18, 2024 Downgrade C Craig Hallum
Buy → Hold $7 +1,913.2% Dec 01, 2022 Upgrade C Craig Hallum
Hold → Buy $6 +1,625.6% Apr 01, 2022 Resumed C Credit Suisse
Neutral $16 +4,501.7% Mar 21, 2022 Downgrade C Citigroup
Buy → Neutral $37 → $15 +4,214.1% Mar 02, 2022 Downgrade T Truist
Buy → Hold Mar 02, 2022 Downgrade E Evercore ISI
Outperform → In-line Jan 18, 2022 Downgrade B Barclays
Overweight → Equal Weight $22 +6,227.3% Jan 07, 2022 Downgrade C Credit Suisse
Outperform → Neutral $45 → $31 +8,815.7% Nov 09, 2021 Downgrade C Craig Hallum
Buy → Hold $75 → $33 +9,390.9% Mar 25, 2021 Downgrade G Goldman
Buy → Neutral $63 +18,019.1% Feb 19, 2021 Downgrade D Deutsche Bank
Buy → Hold $124 → $63 +18,019.1% Feb 01, 2021 Downgrade R Raymond James
Outperform → Mkt Perform Sep 25, 2020 Initiated G Goldman
Buy $101 +28,948.0% Jul 14, 2020 Initiated C Citigroup
Buy $135 +38,726.6% Jul 01, 2020 Initiated S SVB Leerink
Mkt Perform $108 +30,961.3% Apr 16, 2020 Initiated B Barclays
Overweight $150 +43,040.6% Oct 15, 2019 Initiated R Raymond James
Outperform $90 +25,784.4% Sep 12, 2019 Initiated D Deutsche Bank
Buy
Show Previous Ratings
Nov-19-26 09:00AM
Nov-04-26 07:30PM
(Earnings Whispers)
+9.37%
-18.07%
04:42PM
04:15PM
Oct-28-26 09:00AM
05:23PM
Loading…
Oct-27-26 05:23PM
(Earnings Whispers)
+3.11%
Oct-21-26 04:15PM
Oct-13-26 09:00AM
Oct-08-26 09:00AM
Oct-02-26 09:00AM
Sep-24-26 09:00AM
Sep-16-26 09:00AM
Sep-01-26 04:53AM
Aug-20-26 09:00AM
Aug-05-26 01:01AM
04:47PM
Loading…
Aug-04-26 04:47PM
04:15PM
Jul-22-26 05:15PM
Jul-14-26 09:00AM
Jun-10-26 09:00AM
Jun-04-26 09:00AM
May-27-26 01:00PM
May-06-26 05:00PM
(Associated Press)
-7.00%
04:15PM
Apr-22-26 04:15PM
Apr-16-26 09:00AM
Mar-31-26 04:05PM
Mar-12-26 09:00AM
Mar-08-26 10:30AM
Mar-06-26 07:19AM
04:31AM
Loading…
Mar-03-26 04:31AM
Mar-02-26 08:44AM
Feb-26-26 12:07AM
12:02AM
Feb-25-26 05:31PM
(Associated Press Finance)
+8.62%
04:15PM
Feb-19-26 09:00AM
Feb-16-26 09:27AM
Feb-12-26 09:00AM
Feb-09-26 05:50PM
(PR Newswire)
-6.76%
-4.35%
Jan-06-26 04:30PM
(PR Newswire)
-3.22%
-3.33%
08:30AM
Dec-23-25 09:08AM
Dec-18-25 08:30AM
Dec-17-25 11:31PM
Dec-03-25 09:00AM
Nov-30-25 10:39PM
Nov-24-25 04:55PM
(StockStory)
+4.03%
+9.70%
Nov-21-25 05:45PM
Nov-12-25 11:33PM
09:00AM
Nov-06-25 11:35AM
09:00AM
12:08AM
Nov-05-25 05:55PM
05:52PM
04:54PM
(Associated Press Finance)
04:15PM
Nov-04-25 08:42AM
Nov-03-25 10:13PM
Oct-31-25 07:40AM
Oct-30-25 04:15PM
07:15AM
Oct-28-25 12:02AM
Oct-18-25 02:30PM
Oct-15-25 04:05PM
(StockStory)
+5.96%
-7.43%
Oct-12-25 11:35PM
Oct-07-25 04:30PM
(PR Newswire)
-5.70%
-3.02%
03:25PM
10:37AM
Oct-03-25 04:30PM
(PR Newswire)
+4.47%
+18.47%
02:30PM
Oct-02-25 09:00AM
Oct-01-25 09:00AM
Sep-29-25 12:40AM
Sep-25-25 12:33AM
Sep-16-25 12:31AM
Aug-27-25 12:37AM
Aug-21-25 12:46AM
Aug-20-25 09:00AM
Aug-19-25 04:00PM
Aug-13-25 01:44AM
Aug-12-25 03:06AM
Aug-08-25 04:30PM
Aug-06-25 01:10PM
09:38AM
08:45AM
07:39AM
(Associated Press Finance)
07:30AM
Aug-05-25 10:32AM
Aug-04-25 11:03PM
Jul-31-25 07:15AM
Jul-29-25 09:00AM
Jul-28-25 06:10PM
Jul-24-25 12:31AM
Jul-23-25 04:12PM
Jul-22-25 09:00AM
Jul-21-25 04:52PM
Jul-18-25 12:43AM
Jul-15-25 12:02AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SOISTMAN FRANCIS S JR Director Oct 01 '26 Sale 0.70 20,306 14,137 994,915 Oct 02 06:49 PM SOISTMAN FRANCIS S JR Director Oct 02 '26 Sale 0.69 20,306 14,038 974,609 Oct 02 06:49 PM FRANCIS S. SOISTMAN Director Oct 02 '26 Proposed Sale 0.69 20,306 14,038 Oct 02 04:02 PM FRANCIS S. SOISTMAN JR. Director Oct 01 '26 Proposed Sale 0.70 20,306 14,137 Oct 01 04:09 PM SOISTMAN FRANCIS S JR Director Aug 31 '26 Sale 1.14 37,296 42,432 1,052,518 Sep 02 04:19 PM SOISTMAN FRANCIS S JR Director Sep 01 '26 Sale 1.05 37,297 39,277 1,015,221 Sep 02 04:19 PM FRANCIS S. SOISTMAN JR. Director Sep 01 '26 Proposed Sale 1.05 37,297 39,277 Sep 01 04:20 PM FRANCIS S. SOISTMAN JR. Director Aug 31 '26 Proposed Sale 1.14 37,296 42,432 Aug 31 04:42 PM Dolan John Joseph Chief Financial Officer Mar 06 '26 Buy 1.53 25,000 38,190 208,755 Mar 09 04:03 PM DUKE DERRICK A Chief Executive Officer Feb 27 '26 Buy 1.38 187,969 259,397 487,969 Mar 02 04:13 PM
eHealth, Inc. engages in the provision of internet-based health insurance agency services for individuals, families, and small businesses. It operates through the following segments: Medicare and Employer and Individual (E&I). The Medicare segment consists primarily of commissions earned from sale of Medicare-related health insurance plans. The E&I segment includes commissions earned from the sale of individual and family and small business health insurance plans and ancillary products sold to non-Medicare-eligible customers. The company was founded by Vipool Mohanlal Patel in November 1997 and is headquartered in Indianapolis, IN.
CEO & Director Mr. Derrick Anthony Duke C.F.A.
Senior VP & CFO Mr. John Joseph Dolan
Senior VP & Chief Revenue Officer Ms. Michelle M. Barbeau
Senior Vice President of Investor Relations & Corporate Development Ms. Kate Sidorovich CFA
Senior VP Mr. Gavin Guy Galimi